Ceftaroline Fosamil Injection, Powder, Lyophilized, For Solution
Product Images NDC 60505-6124

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ceftaroline Fosamil (NDC 60505-6124). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-label-400mg-10s.jpg (Carton Label 400mg 10s)

Carton-label-400mg-10s.jpg (Carton Label 400mg 10s)
The text provided seems to be instructions and information related to a medication called Ceftaroline Fosamil, typically used for intravenous infusion. It includes details about dosage, storage temperature, constituents, and dilution process for the solution. The medication contains 400 mg of Ceftaroline Fosamil powder and L-arginine as a buffering agent. It mentions the types of solutions recommended for constitution and further dilution. The color of the solution may vary depending on concentration and storage conditions, but it states that potency is not affected when stored as recommended. Additionally, it provides guidance on discarding unused portions and ensuring proper dilution before infusion.*
FDA Label Image

Carton-label-600mg-10s.jpg (Carton Label 600mg 10s)

Carton-label-600mg-10s.jpg (Carton Label 600mg 10s)
This is a medication information sheet for Ceftaroline Fosamil injection. It provides details on dosage, composition, and storage instructions. The text mentions that each vial contains 600mg of Ceftaroline Fosamil powder for constitution into an intravenous infusion. The constituted solution needs to be maintained at a pH of 4.8 to 6.5. Storage temperature recommendations are between 15°C to 30°C (59°F to 86°F). The text also specifies that after constitution with sterile water or saline solutions, the resultant solution will contain approximately 30 mg/mL. It is highlighted that the constituted solution must be further diluted before intravenous infusion. Additionally, it mentions that Ceftaroline Fosamil for injection infusion solutions can vary in color from clear to dark yellow based on concentration and storage conditions.*
FDA Label Image

Structure (Structure)

FDA Label Image

Vial-label-400mg.jpg (Vial Label 400mg)

Vial-label-400mg.jpg (Vial Label 400mg)
This text provides instructions on how to prepare a medication solution for intravenous infusion. It mentions the dilution process, storage conditions, dosage information, and manufacturer details. The medication is Ceftaroline Fosamil with a concentration of 20 mg/mL once diluted. The vial contains 400 mg and should be discarded after use. Prior to constitution, it should be stored at 25°C (77°F) with excursions allowed to 15-30°C (59-86°F).*
FDA Label Image

Vial-label-600mg.jpg (Vial Label 600mg)

Vial-label-600mg.jpg (Vial Label 600mg)
This text is a set of instructions for the preparation and administration of Ceftaroline Fosamil, specifying the volume of diluent needed, the concentration to be obtained, storage conditions, the manufacturer, dosage information, and the intended use for intravenous infusion. It also provides the contact details for the manufacturer and the company that manufactures the product.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.